Lexaria Bioscience Corp. (LEXX:NASDAQ) closed at $3.08 on October 23, 2026, up 3.01% on the day. The stock trades 85.7% below its 52-week high of $21.60 and 26.7% above its 52-week low of $2.43. Lexaria Bioscience Corp. is part of the Health Care sector.
In 249 trading sessions since October 23, 2025, LEXX closed higher on 123 days (49%). Its best day was August 13, 2026 (+32.35%) and its worst was September 10, 2026 (-38.64%). The stock moved 10% or more in a single session 29 times.
Lexaria Bioscience Corp's drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream. DehydraTECH increases absorption by up to 5-10x, reduces time of onset from 1 - 2 hours to minutes, and masks unwanted tastes. With 18 patents granted for use with nicotine, NSAIDs and cannabinoids; and over 60 patents pending for antiviral drugs; hormones, PDE5 inhibitors, and more, our areas of focus include heart disease, viruses, Parkinsons and more.
Find more stocks like LEXX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.